Tildrakizumab for moderate to severe plaque psoriasis

First Page		Document Content
		Tildrakizumab for moderate to severe plaque psoriasis Add to Reading List Source URL: www.hsc.nihr.ac.uk Download Document from Source Website File Size: 177,36 KB Share Document on Facebook